Blueprint Medicines Corp Costs and Expenses in USD from 2018 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Blueprint Medicines Corp quarterly/annual Costs and Expenses history and growth rate from 2018 to Q1 2025.
  • Blueprint Medicines Corp Costs and Expenses for the quarter ending March 31, 2025 was $190M, a 8.9% increase year-over-year.
  • Blueprint Medicines Corp Costs and Expenses for the twelve months ending March 31, 2025 was $736M, a 1.84% increase year-over-year.
  • Blueprint Medicines Corp annual Costs and Expenses for 2024 was $721M, a 2.01% decline from 2023.
  • Blueprint Medicines Corp annual Costs and Expenses for 2023 was $736M, a 0.8% decline from 2022.
  • Blueprint Medicines Corp annual Costs and Expenses for 2022 was $742M, a 9.79% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)

Blueprint Medicines Corp Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $736M $190M +$15.6M +8.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $721M $188M +$10.5M +5.93% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-13
Q3 2024 $710M $177M -$8.39M -4.52% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $719M $181M -$4.35M -2.34% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $723M $175M -$12.6M -6.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q4 2023 $736M $177M -$11.5M -6.11% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-13
Q3 2023 $747M $186M -$4.71M -2.48% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $752M $186M -$8.63M -4.45% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $761M $187M +$19M +11.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $742M $189M -$235M -55.4% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-13
Q3 2022 $976M $190M +$49M +34.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $927M $194M +$58.4M +43% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $869M $169M +$46.7M +38.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $822M $423M +$303M +252% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $519M $141M +$29.5M +26.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $489M $136M +$2.43M +1.82% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $487M $122M +$1.99M +1.66% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $485M $120M -$839K -0.69% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $486M $112M +$4.65M +4.34% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $481M $133M +$24.4M +22.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $457M $120M +$29M +32% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $428M $121M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-17
Q3 2019 $107M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $109M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $90.8M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06

Blueprint Medicines Corp Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $721M -$14.8M -2.01% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 $736M -$5.9M -0.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 $742M -$80.5M -9.79% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2021 $822M +$337M +69.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $485M +$57.2M +13.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $428M +$136M +46.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-17
2018 $292M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.